Southern Capital Advisors LLC Has $4.76 Million Holdings in iShares Biotechnology ETF $IBB

Posted by George Bondi on Jun 22nd, 2026

Southern Capital Advisors LLC raised its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 20.7% in the first quarter, Holdings Channel reports. The firm owned 28,186 shares of the financial services provider’s stock after buying an additional 4,833 shares during the period. iShares Biotechnology ETF accounts for 2.2% of Southern Capital Advisors LLC’s investment portfolio, making the stock its 12th largest holding. Southern Capital Advisors LLC’s holdings in iShares Biotechnology ETF were worth $4,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC bought a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $201,000. AQR Capital Management LLC acquired a new stake in iShares Biotechnology ETF in the first quarter valued at approximately $455,000. Millennium Management LLC grew its position in iShares Biotechnology ETF by 140.8% in the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after acquiring an additional 143,893 shares in the last quarter. M&T Bank Corp grew its position in iShares Biotechnology ETF by 39.3% in the second quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after acquiring an additional 750 shares in the last quarter. Finally, Walleye Capital LLC increased its stake in shares of iShares Biotechnology ETF by 26.8% during the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after purchasing an additional 985 shares during the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $173.64 on Monday. The company’s fifty day moving average is $170.61 and its 200-day moving average is $170.67. iShares Biotechnology ETF has a 12 month low of $123.61 and a 12 month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were issued a $0.0238 dividend. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.